1.
Clin Case Rep
; 11(3): e6990, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36950671
RESUMO
Patients with acute coronary syndrome (ACS), failed percutaneous coronary intervention (PCI) and with an indication for emergent coronary artery bypass graft surgery (CABG) are at an increased risk of perioperative bleeding. Integration of the CytoSorb® (CS) adsorber into the cardiopulmonary bypass appears to bind prasugrel and minimize the risk of perioperative bleeding.
2.
Clin Case Rep
; 10(1): e05272, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35079387
RESUMO
Rhabdomyolysis (RM) is a potentially life-threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb®) might increase its efficacy.